Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2012-12-17

Clinical Trial Update: Flavonoids in the Treatment of Endothelial Dysfunction in Children With Diabetes [NA]

View source ↗

Summary

A clinical trial evaluating flavonoids for endothelial dysfunction in children with diabetes has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Flavonoids

Snippet

Sponsor: Texas Tech University Health Sciences Center | Conditions: Diabetic Nephropathy, Endothelial Dysfunction | NA | Status: WITHDRAWN